Skip to main content
QNTM
NASDAQ Life Sciences

Quantum BioPharma Insiders Lift Voting Control to 68% Via C$80.86 MVS Placement; Reverse-Split Authority Approved

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2
Mkt Cap
$15.69M
52W Low
$1.91
52W High
$12.42
52W Position info
4.7% above low
Off High info
84% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

QNTM is trading near its 52-week low of $1.91 (4.7% above the low).

Summary

Quantum BioPharma closed a C$80.86 placement of 26 Class A Multiple Voting Shares to two insider vehicles, lifting their combined voting control to about 68%. Shareholders also approved authority for a reverse split of up to 10-for-1 and a name change.


Key Events · Corporate Governance and Compliance · QNTM

  • Insider MVS Placement Closes

    26 Class A Multiple Voting Shares were issued at C$3.11 each for aggregate gross proceeds of C$80.86, priced off the US$2.21 Nasdaq trading price of the Class B shares on November 9, 2026.

  • Insider Voting Control Jumps to 68%

    Xorax Family Trust (CEO Zeeshan Saeed) and Fortius Research and Trading Corp. (director Anthony Durkacz) each acquired 13 shares, moving combined voting power from approximately 57.01% to approximately 68.22%.

  • Reverse Split Authority Approved

    A special resolution lets the board consolidate shares at up to 10 pre-consolidation shares for 1 post-consolidation share, at its discretion; 97.0% of votes cast were in favor.

  • Name Change Authority Approved

    Shareholders authorized a company name change at the board's discretion, with 97.6% support.


Analysis · QNTM · Life Sciences

Two insider vehicles — Xorax Family Trust (CEO Zeeshan Saeed) and Fortius Research and Trading Corp. (director Anthony Durkacz) — each bought 13 Class A Multiple Voting Shares at C$3.11, lifting their combined voting power from roughly 57% to roughly 68%. The cash raised is trivial (C$80.86 total), so this is a control transaction, not a capital raise: the dual-class structure lets insiders hold a supermajority of votes while owning a small slice of the equity. Shareholders also authorized a consolidation of up to 10-for-1 and a name change, both at the board's discretion — with the stock at $2.00 and near its 52-week low of $1.91, a reverse split is a plausible next step to defend the Nasdaq listing. Minority holders should note the MVS Issuance Resolution passed with only 65.8% support, with 34.2% voting against.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, QNTM was trading at $2.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $1.91 to $12.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QNTM - Latest Insights

QNTM
Nov 12, 2026, 4:06 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $1.80 info
Change: +$0.0185 (+1%) info
Market Cap: $14.396M info
QNTM
Oct 08, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $1.80 info
Change: -$1.29 (-42%) info
Market Cap: $14.396M info
QNTM
Oct 06, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.27
Real-time Price: $1.80 info
Change: -$1.47 (-45%) info
Market Cap: $14.396M info
QNTM
Sep 01, 2026, 8:28 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.02
Real-time Price: $1.80 info
Change: -$1.22 (-40%) info
Market Cap: $14.396M info
QNTM
Aug 14, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $1.80 info
Change: -$1.68 (-48%) info
Market Cap: $14.396M info